top of page
All Articles


Vaping and Cancer Risk: What Ae know So Far
Vaping could increase the risk of cancer, according to emerging research, but health officials stress the evidence is still developing and the dangers remain significantly lower than smoking. A recent review has suggested e-cigarettes are “likely” to contribute to lung and oral cancers, drawing on laboratory studies, animal experiments and clinical observations. Researchers found that users can be exposed to heavy metals, nicotine and other potentially cancer-linked chemicals
Apr 282 min read


Cybercrime 2026: Evolution, Not Revolution
Warnings about artificial intelligence transforming cybercrime often sound dramatic, but the reality is more uneven. Recent research from major tech companies suggests criminals are experimenting with AI tools in ways that could shift how attacks are carried out. One Google report found that some hackers were using generative systems to tweak malware on the fly, potentially helping it slip past traditional detection methods. At first glance, that points to a significant escal
Apr 262 min read


The Human Ingredient; Will Recipes Lose Their Roots
Artificial intelligence is edging into the kitchen, promising to reshape how meals are planned, prepared and even imagined. The shift is being framed as a leap forward in convenience, but it also raises quieter questions about creativity and ownership. Early attempts at AI-generated cooking advice did little to inspire confidence. Widely shared errors included improbable ingredient suggestions and unsafe instructions, reinforcing the sense that the technology was not ready fo
Apr 263 min read


AI is racing to fix the future. It may be breaking the planet in the process.
The technology designed to help solve global crises is quietly intensifying one of the biggest: the strain on the planet itself.
Apr 214 min read


Is OpenAI's Entry Into Diet Drugs Moving Too Far, Too Quickly?
Novo Nordisk’s latest tie-up with OpenAI is being billed as a leap forward for medicine: a marriage of pharmaceutical heft and cutting-edge artificial intelligence that promises to deliver “new and better” treatments faster. But beneath the optimism lies a more complicated question: faster for what, and at what cost? The Danish drugmaker behind blockbuster weight-loss injections is the latest in a growing line of companies turning to AI to accelerate drug discovery. The techn
Apr 192 min read


Allbirds' AI Pivot Risks Unravelling Its Green Credentials
Allbirds, once held up as a poster child for low-impact fashion, is attempting a radical reinvention, but its new direction raises uncomfortable questions about the environmental cost of the tech that it hopes will save it. The San Francisco-founded company built its reputation on wool trainers that were marketed as a greener alternative to synthetic footwear, winning over environmentally conscious consumers and high-profile supporters alike. Now, however, it is seeking to re
Apr 192 min read
bottom of page

